Cargando…
Sequencing for an interdisciplinary molecular tumor board in patients with advanced breast cancer: experiences from a case series
Purpose: High throughput panel sequencing to tailor therapy in precision oncology promises to improve outcome in patients with metastatic breast cancer. However, data that clearly show any benefit from such an approach is still pending. Materials and Methods: We performed a retrospective analysis of...
Autores principales: | Walter, Christina, Hartkopf, Andreas, Koch, Andre, Klaumünzer, Marion, Schulze, Martin, Grischke, Eva-Maria, Taran, Florin-Andrei, Brucker, Sara, Battke, Florian, Biskup, Saskia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476733/ https://www.ncbi.nlm.nih.gov/pubmed/32934773 http://dx.doi.org/10.18632/oncotarget.27704 |
Ejemplares similares
-
Distribution of the 21-Gene Breast Recurrence Score in Patients with Primary Breast Cancer in Germany
por: Walter, Vincent P., et al.
Publicado: (2020) -
Electrochemotherapy – Supplementary Treatment for Loco-regional Metastasized Breast Carcinoma Administered to Concomitant Systemic Therapy
por: Grischke, Eva-Maria, et al.
Publicado: (2017) -
The question of WGS’s clinical utility remains unanswered
por: Battke, Florian, et al.
Publicado: (2021) -
Recurrence Score(®) Result Impacts Treatment Decisions in Hormone Receptor-Positive, HER2-Negative Patients with Early Breast Cancer in a Real-World Setting—Results of the IRMA Trial
por: Dannehl, Dominik, et al.
Publicado: (2022) -
Simultaneous Detection of Disseminated and Circulating Tumor Cells in Primary Breast Cancer Patients
por: Hartkopf, Andreas D., et al.
Publicado: (2016)